Sign in to follow
Search Results

0 results for 'Pfizer'

You can use to get even better search results
February 13, 2023 | Litigation Daily

Litigation Leaders: Dan Weiner of Hughes Hubbard & Reed on the Benefits of 'Deep Industry Focus'

"As the saying goes, 'A little knowledge is a dangerous thing'; we pride ourselves in knowing both the law and the subject matter of our cases, inside and out."
10 minute read
February 10, 2023 | Law.com

Change in Job Sites for Non-Vaccinated Employee Was Not Discriminatory, Retaliatory, Federal Judge Rules

"Leggo is evidently upset that he has not been able to work the full extent as other M.C. Dean employees because by refusing to disclose his vaccination status, he has been deemed unvaccinated," Brinkema wrote. "[H]owever, the pleadings filed by plaintiff make clear that M.C. Dean's COVID-19 policy was a response to the vaccination and testing requirements of its customers given the ongoing pandemic, and his claims that M.C. Dean discriminated or retaliated against him on a perceived disability are therefore implausible and conclusory."
4 minute read
February 07, 2023 | Insurance Coverage Law Center

Just Whistle While You Work? New Jersey Case is "A Game Changer for Workplace Lawsuits"

A case of first impression out of New Jersey signals a major shift in employment-related litigation. The original version of this story was published on New Jersey Law Journal.
5 minute read
February 07, 2023 | Daily Report Online

Man Sues Law Firm and Others, Seeking $5M for Lost Job Chance

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
February 03, 2023 | New Jersey Law Journal

A New COVID Ruling Just Came Down—And It's a Game Changer for Workplace Lawsuits

The decision goes beyond the scope of a November 2020 ruling in "Loeb v. Vantage Custom Classics," which allowed a plaintiff to proceed with a whistleblower suit related to COVID, said Christopher Eibeler, the plaintiff's lawyer.
5 minute read
Law Journal Press | Digital Book Pennsylvania Commonwealth Court Rules 2024 Authors: View this Book

View more book results for the query "Pfizer"

January 30, 2023 | Law.com

Scientific Lab Behind Dozens of Product Recalls Under the Microscope

In lawsuits, GlaxoSmithKline, Unilever and others are challenging the scientific methods used by Valisure, the Connecticut laboratory whose reports have prompted recalls, and subsequent class actions, over drugs, sunscreen and dry shampoo.
10 minute read
January 26, 2023 | New York Law Journal

Ruling Consolidates Zantac Lawsuits Filed in New York State Courts

The New York State Litigation Coordinating Panel on Thursday combined some 40 active cases for pre-trial litigation in New York County. Any future ranitidine-related personal injury cases filed in the state will proceed under this same action, according to the panel.
2 minute read
January 24, 2023 | Corporate Counsel

Boards' Lack of Tech Savvy Poses Challenges for CLOs

"The lawyers in our survey gave remarkably consistent comments. ... They see the key risk as the board. They worry over its composition, quality and experience," Baker McKenzie wrote in a recently released report.
7 minute read
January 20, 2023 | Connecticut Law Tribune

Siding With Plaintiffs, Federal Judges Kicks 9 Lawsuits Against Zantac Manufacturers Back to State Court

"Could the plaintiffs have filed a motion that made their intent clearer, such as by expressly disclaiming any request to consolidate for trial? Yes, they could have—and no doubt wished they did. But my role is not to grade or foot-fault the quality of the plaintiffs' filings. I must decide if the plaintiffs actually proposed consolidation for a joint trial. They did not," U.S. District Judge Jeffrey Alker Meyer wrote.
6 minute read
January 09, 2023 | New York Law Journal

Industry Fights Back Against Restrictions on Pharmaceutical Manufacturers' Ability To Offer Drug Cost-Sharing Subsidies

In 2022, the Office of Inspector General and at least two federal courts took a clear stance against pharmaceutical manufacturers' attempts to offer cost-sharing subsidies to Medicare beneficiaries for certain drugs, but the industry is fighting back. Pharmaceutical manufacturers and lobbying groups are challenging these administrative restrictions in a concerted effort to increase access to life-saving medications.
15 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources